PIDILITINDBSEPIDILITE INDUSTRIES LTD· Chemicals - SpecialityLowNeutral
Announced Wed, 28 Oct, 2026 · 19:07 IST

Q2 FY27 sales rise 21.7%, PAT up 10.4% despite margin compression

PIDILITIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction

Awaiting price reaction for this filing.

AI summary

Pidilite reported standalone Q2 FY27 sales of Rs 3,982 crore, up 21.7%, with 10.7% underlying volume growth. PAT rose 10.4% to Rs 647 crore, but EBITDA was nearly flat at Rs 811 crore and margin fell to 20.4% from 24.7% amid input cost inflation. H1 sales grew 22.0% and PAT 19.5%.

Likely market impact

Strong sales and PAT growth supports the stock, but weak quarterly EBITDA growth and a 4.3 percentage point margin drop could limit near-term gains.